Monday, November 11, 2019
- 9:00AM-11:00AM
-
Abstract Number: 1735
Clinical Variables Influencing Prednisone Dosing Towards the Development of Corticosteroid Treatment Algorithms in Pediatric Proliferative Lupus Nephritis
Pediatric Rheumatology – ePoster II: SLE, Juvenile Dermatomyositis, & Scleroderma- 9:00AM-11:00AM
-
Abstract Number: 1552
Clinically Meaningful Improvement in Skin and Nail Psoriasis in Bio-naïve Active Psoriatic Arthritis Patients Treated with Intravenous Golimumab: Results Through Week 52 from a Phase-3 Study
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Treatment of Axial Spondyloarthritis & Psoriatic Arthritis- 9:00AM-11:00AM
-
Abstract Number: 1048
Clonally Expanded CD4+ Cytotoxic T Cells, Endothelial Cell Apoptosis and the Pathogenesis of Early Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: 1736
Cognitive Impairment in Childhood-Onset Systemic Lupus Erythematosus: Early Detection with MRI Spectroscopy and Its Association with MOG Antibodies
Pediatric Rheumatology – ePoster II: SLE, Juvenile Dermatomyositis, & Scleroderma- 9:00AM-11:00AM
-
Abstract Number: 1622
Cognitive Impairments in SLE Negatively Related to Participation and Quality of Life: A Systematic Review
SLE – Clinical Poster II: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 1754
Comorbidities and Treatments in United States Youth with Chronic Musculoskeletal Pain
Pediatric Rheumatology – ePoster II: SLE, Juvenile Dermatomyositis, & Scleroderma- 9:00AM-11:00AM
-
Abstract Number: 1397
Comparative Effectiveness of Tocilizumab in Combination with Methotrexate versus Tumor Necrosis Factor Inhibitors (TNFis) in Combination with Methotrexate in Patients with Rheumatoid Arthritis with Prior Exposure to TNFis
RA – Treatments Poster II: Established Treatments- 9:00AM-11:00AM
-
Abstract Number: 1496
Comparative Effectiveness of Ustekinumab and TNF Inhibitors in Patients with Psoriatic Arthritis in a Real-world, Multicenter Study
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Treatment of Axial Spondyloarthritis & Psoriatic Arthritis- 9:00AM-11:00AM
-
Abstract Number: 1645
Comparison of Automated Capture and Analysis System of Sublingual Microvessels and Nailfold Videocapillarscopy for Microvascular Assessment in Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 1452
Comparison of Clinical Phenotype, Serological Characteristics and Histologic Features Between Males and Females Patients with Primary Sjögren’s Syndrome (pSS)
Sjögrenʼs Syndrome – Basic & Clinical Science Poster II- 9:00AM-11:00AM
-
Abstract Number: 1634
Comparison of Different Pulmonary Hypertension Screening Algorithms in Patients with Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 1475
Comparison of Different Remission Indices in Patients with Psoriatic Arthritis: A Post Hoc Analysis of Data from Phase 3 Tofacitinib Studies
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Treatment of Axial Spondyloarthritis & Psoriatic Arthritis- 9:00AM-11:00AM
-
Abstract Number: 1256
Comparison of FMF Patients with Age of Onset Before 20 versus 40 Years and Over
Miscellaneous Rheumatic & Inflammatory Disease Poster II: Autoinflammation Related Diseases & Therapies- 9:00AM-11:00AM
-
Abstract Number: 1409
Comparison of Healthcare Resource Utilization and Costs of Type 2 Diabetes Mellitus (T2DM)-Related Complications in Medicare Beneficiaries with Rheumatoid Arthritis (RA) and T2DM Who Initiated Treatment with Abatacept versus Other Targeted Disease-Modifying Anti-Rheumatic Drugs